230 related articles for article (PubMed ID: 15596677)
1. Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD.
Vernooy JH; Lindeman JH; Jacobs JA; Hanemaaijer R; Wouters EF
Chest; 2004 Dec; 126(6):1802-10. PubMed ID: 15596677
[TBL] [Abstract][Full Text] [Related]
2. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
[TBL] [Abstract][Full Text] [Related]
3. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
4. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
[TBL] [Abstract][Full Text] [Related]
5. Transient elevation of neutrophil proteinases in induced sputum during COPD exacerbation.
Ilumets H; Rytilä PH; Sovijärvi AR; Tervahartiala T; Myllärniemi M; Sorsa TA; Kinnula VL
Scand J Clin Lab Invest; 2008; 68(7):618-23. PubMed ID: 19378434
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of cyclooxygenase-2 and matrix metalloproteinase-2 and airflow obstruction in patients with chronic obstructive pulmonary disease].
Chen Y; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):324-7. PubMed ID: 15949313
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression.
Baraldo S; Bazzan E; Zanin ME; Turato G; Garbisa S; Maestrelli P; Papi A; Miniati M; Fabbri LM; Zuin R; Saetta M
Chest; 2007 Dec; 132(6):1733-40. PubMed ID: 17646237
[TBL] [Abstract][Full Text] [Related]
8. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
Beeh KM; Beier J; Kornmann O; Buhl R
Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147
[TBL] [Abstract][Full Text] [Related]
9. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis.
Vignola AM; Riccobono L; Mirabella A; Profita M; Chanez P; Bellia V; Mautino G; D'accardi P; Bousquet J; Bonsignore G
Am J Respir Crit Care Med; 1998 Dec; 158(6):1945-50. PubMed ID: 9847290
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.
Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728
[TBL] [Abstract][Full Text] [Related]
11. [The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models].
Li H; Cui D; Tong X; Ma N; Gao Y; Cui X; Lu L; Wang D; Liang Y
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):393-8. PubMed ID: 12137602
[TBL] [Abstract][Full Text] [Related]
12. Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study.
Louhelainen N; Stark H; Mazur W; Rytilä P; Djukanovic R; Kinnula VL
BMC Pulm Med; 2010 Mar; 10():13. PubMed ID: 20226090
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of collagenase activity, matrix metalloproteinase-8, and matrix metalloproteinase-13 in horses with chronic obstructive pulmonary disease.
Raulo SM; Sorsa TA; Kiili MT; Maisi PS
Am J Vet Res; 2001 Jul; 62(7):1142-8. PubMed ID: 11453493
[TBL] [Abstract][Full Text] [Related]
14. Elevated MMP-12 protein levels in induced sputum from patients with COPD.
Demedts IK; Morel-Montero A; Lebecque S; Pacheco Y; Cataldo D; Joos GF; Pauwels RA; Brusselle GG
Thorax; 2006 Mar; 61(3):196-201. PubMed ID: 16308335
[TBL] [Abstract][Full Text] [Related]
15. [Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease].
Piesiak P; Brzecka A; Kosacka M; Passowicz-Muszyńska E; Dyła T; Jankowska R
Pol Merkur Lekarski; 2011 Nov; 31(185):270-3. PubMed ID: 22299526
[TBL] [Abstract][Full Text] [Related]
16. Induced sputum metalloproteinases and their inhibitors in relation to exhaled nitrogen oxide and sputum nitric oxides and other inflammatory cytokines in patients with chronic obstructive pulmonary disease.
Ziora D; Dworniczak S; Kozielski J
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():809-17. PubMed ID: 19218708
[TBL] [Abstract][Full Text] [Related]
17. Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD.
Babusyte A; Stravinskaite K; Jeroch J; Lötvall J; Sakalauskas R; Sitkauskiene B
Respir Res; 2007 Nov; 8(1):81. PubMed ID: 18001475
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD.
Segura-Valdez L; Pardo A; Gaxiola M; Uhal BD; Becerril C; Selman M
Chest; 2000 Mar; 117(3):684-94. PubMed ID: 10712992
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases -8 and -9 in the Airways, Blood and Urine During Exacerbations of COPD.
Cane JL; Mallia-Millanes B; Forrester DL; Knox AJ; Bolton CE; Johnson SR
COPD; 2016; 13(1):26-34. PubMed ID: 26418236
[TBL] [Abstract][Full Text] [Related]
20. [Markers of airway remodeling in induced sputum from healthy smokers].
Avilés B; Belda J; Margarit G; Bellido-Casado J; Martínez-Brú C; Casan P
Arch Bronconeumol; 2006 May; 42(5):235-40. PubMed ID: 16740239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]